The story of Sildenafil offers a complex case study for investors eyeing drug companies. While early sales were explosive, recent patent expiration and the arrival of cheaper versions have significantly affected https://larafcya809271.tblogz.com/the-blue-pill-and-pharma-a-precarious-stake-54222268